Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.95% | 171.30 | 1.3% | $495.18m | |
| BIIB | Biogen Inc. | 0.91% | 235.04 | 1.3% | $480.36m | |
| CELG | Celgene Corporation | 0.11% | 96.36 | 1.3% | $457.23m | |
| GILD | Gilead Sciences, Inc. | -0.03% | 66.50 | 0.9% | $434.72m | |
| ILMN | Illumina, Inc. | 2.08% | 312.83 | 3.5% | $317.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.27% | 320.09 | 2.6% | $298.61m | |
| A | Agilent Technologies, Inc. | -0.50% | 67.98 | 1.6% | $207.68m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.92% | 172.37 | 1.9% | $181.17m | |
| EXAS | Exact Sciences Corporation | -2.10% | 94.91 | 25.3% | $163.66m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.97% | 127.55 | 2.0% | $149.64m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.25% | 87.69 | 4.3% | $118.55m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.36% | 121.62 | 14.7% | $112.14m | |
| INCY | Incyte Corporation | 0.43% | 79.02 | 2.5% | $105.72m | |
| IONS | Ionis Pharmaceuticals, Inc. | -0.98% | 68.56 | 8.2% | $98.74m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.09% | 67.81 | 9.2% | $94.94m |
Company Profile
Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.